Company Filing History:
Years Active: 1980-1982
Title: Eckehard K Cuny: Innovator in Pharmaceutical Chemistry
Introduction
Eckehard K Cuny is a notable inventor in the field of pharmaceutical chemistry, recognized for his contributions to the development of novel compounds with potential therapeutic applications. He is based in Seeheim, Germany, and has been instrumental in advancing the understanding of benzologs and quinazoline derivatives.
Latest Patents
Cuny holds two patents that focus on innovative chemical compounds. His first patent involves Lin-benzoaminopurinols, which are novel benzologs or pyrazolo-quinazoline derivatives. These compounds are designed with specific structural features that enhance their biological activity. The patent outlines two methods for producing these compounds, starting from either an indazole or a quinazoline precursor. The second patent details novel quinazoline derivatives that are structurally related to allopurinol, a well-known drug used in the treatment of gout. These new compounds are expected to complement or replace allopurinol in therapeutic applications.
Career Highlights
Cuny's career is marked by significant achievements in the synthesis of biologically active compounds. His work has led to the development of novel drugs that have the potential to improve patient outcomes in various medical conditions. His innovative approaches to chemical synthesis have garnered attention in the pharmaceutical industry.
Collaborations
Cuny has collaborated with esteemed colleagues, including Frieder W Lichtenthaler and Alfred R Moser. These partnerships have contributed to the advancement of research in pharmaceutical chemistry and the development of new therapeutic agents.
Conclusion
Eckehard K Cuny's contributions to the field of pharmaceutical chemistry through his innovative patents and collaborations highlight his role as a leading inventor. His work continues to influence the development of new drugs that may significantly impact healthcare.